David Matthew Feliciano obtained a Bachelor of Science in Biochemical Pharmacology in 2003 and a PhD in Pharmacology in 2008 from the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He joined Clemson University as an Assistant Professor in the Department of Biological Sciences in 2013 and was promoted to Associate Professor with tenure in 2019. In 2008, he was an NIH T32 postdoctoral fellow at Yale University and was awarded an Epilepsy Foundation fellowship in 2009 and an NIH Ruth L. Kirschstein National Research Service Award (NRSA) fellowship in 2010 while working in the Department of Neurosurgery in the School of Medicine at Yale University. Since establishing a laboratory at Clemson University, Dr. Feliciano has been awarded grants from the National Institutes of Health, Department of Defense, and Whitehall Foundation, has served on federal and international grant review panels, and given numerous invited talks. In 2021, Dr. Feliciano was a visiting scientist at Boston Children’s Hospital and Harvard Medical School. The Feliciano lab translates fundamental biological knowledge about the brain into clinically relevant ideas. They achieve this by studying gene mutations that alter brain architecture.

Angelique Bordey was a Postdoctoral Fellow at the University of Alabama. She received an MS degree in Chemistry from the National School of Engineering in Lyon (ESCIL), France. She graduated from Louis Pasteur University with an MS in Neurophysiology and a PhD in Neuroscience. She is currently a Professor of Neurosurgery, and Cellular & Molecular Physiology at Yale University. She also is an active participant in the teaching and training of graduate and medical students at Yale School of Medicine. She serves as an Editor for several journals, has served on the advisory board of CURE epilepsy and the Tuberous Sclerosis Complex (TSC) Alliance preclinical consortium, and is now a board member for the TSC Alliance. She has served as a permanent member on several grant review committees and NIH study sections. Finally, she is a McKnight awardee and holds several grants as well as patents for the treatment of epilepsy. Her research interests include Autistic Disorder; Epilepsy; Central Nervous System Diseases; Cortical Malformations; Neurologic Manifestations; mTOR; Cortical Development; Neurogenesis.